Summary
Zoetis Inc. (ZTS) reported strong financial results for the second quarter and first half of 2021, demonstrating significant revenue growth and improved profitability. Revenue for the three months ended June 30, 2021, increased by 26% to $1.95 billion, and by 24% for the six months ended June 30, 2021, to $3.82 billion. This growth was driven by a combination of increased product volume, particularly in companion animal products like the new Simparica Trio parasiticide, and a favorable market recovery from the COVID-19 pandemic's impact in the prior year. Net income attributable to Zoetis Inc. saw a substantial increase of 36% to $512 million for the quarter and 34% to $1.07 billion for the first half of the year. This robust profitability was supported by strong revenue growth, effective cost management, and a slightly improved effective tax rate. The company's operational performance was strong, with operational revenue growth of 22% for the quarter and 22% for the first half, indicating resilience and effective execution across its global segments, with both the U.S. and International segments contributing positively.
Financial Highlights
52 data points| Revenue | $1.95B |
| Cost of Revenue | $568.00M |
| Gross Profit | $1.38B |
| SG&A Expenses | $495.00M |
| Interest Expense | $57.00M |
| Net Income | $511.00M |
| EPS (Basic) | $1.08 |
| EPS (Diluted) | $1.07 |
| Shares Outstanding (Basic) | 474.80M |
| Shares Outstanding (Diluted) | 477.00M |
Key Highlights
- 1Total revenue for Q2 2021 surged by 26% year-over-year to $1.95 billion, driven by a 22% operational increase.
- 2Net income attributable to Zoetis Inc. grew by 36% to $512 million in Q2 2021.
- 3Diluted earnings per share (EPS) increased by 35% to $1.07 in Q2 2021.
- 4Both U.S. and International segments reported significant revenue growth, with companion animal products showing particularly strong performance.
- 5The company resumed its share repurchase program in January 2021, indicating confidence and commitment to returning value to shareholders.
- 6Despite increased SG&A and R&D expenses, the company maintained strong margins and operational efficiency.
- 7Positive foreign exchange movements contributed to reported revenue growth, alongside strong underlying operational performance.